Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine-Artesunate vs Mefloquine+Artesunate in Acute Falciparum Malaria
NCT00403260Phase 3Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Jan 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of pyronaridine in Plasmodium falciparum malaria, sponsored by Medicines for Malaria Venture. Started Jan 2007; status: completed.
02
Drugs
pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00403260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403260.